- Clinical Trials
- April 2024
- 60 Pages
Global
From €1586EUR$1,600USD£1,316GBP
€1983EUR$2,000USD£1,646GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1586EUR$1,600USD£1,316GBP
€1983EUR$2,000USD£1,646GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1586EUR$1,600USD£1,316GBP
€1983EUR$2,000USD£1,646GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €991EUR$1,000USD£823GBP
€1239EUR$1,250USD£1,028GBP
- Drug Pipelines
- April 2024
- 80 Pages
Global
From €1983EUR$2,000USD£1,646GBP
€2478EUR$2,500USD£2,057GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €991EUR$1,000USD£823GBP
€1239EUR$1,250USD£1,028GBP
- Report
- February 2024
- 168 Pages
Global
From €6304EUR$6,360USD£5,233GBP
€7880EUR$7,950USD£6,541GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1190EUR$1,200USD£987GBP
€1487EUR$1,500USD£1,234GBP
- Drug Pipelines
- January 2024
- 90 Pages
Global
From €1586EUR$1,600USD£1,316GBP
€1983EUR$2,000USD£1,646GBP
- Clinical Trials
- January 2024
- 120 Pages
Global
From €1983EUR$2,000USD£1,646GBP
€2478EUR$2,500USD£2,057GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €991EUR$1,000USD£823GBP
€1239EUR$1,250USD£1,028GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €991EUR$1,000USD£823GBP
€1239EUR$1,250USD£1,028GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €991EUR$1,000USD£823GBP
€1239EUR$1,250USD£1,028GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €991EUR$1,000USD£823GBP
€1239EUR$1,250USD£1,028GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €991EUR$1,000USD£823GBP
€1239EUR$1,250USD£1,028GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €991EUR$1,000USD£823GBP
€1239EUR$1,250USD£1,028GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1190EUR$1,200USD£987GBP
€1487EUR$1,500USD£1,234GBP
- Clinical Trials
- January 2024
- 90 Pages
Global
From €1983EUR$2,000USD£1,646GBP
€2478EUR$2,500USD£2,057GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1190EUR$1,200USD£987GBP
€1487EUR$1,500USD£1,234GBP
- Report
- January 2024
- 120 Pages
Global
From €6304EUR$6,360USD£5,233GBP
€7880EUR$7,950USD£6,541GBP
The Analgesics market is a sector of the pharmaceutical industry that focuses on the production and sale of drugs used to relieve pain. Analgesics are used to treat a variety of conditions, including headaches, muscle pain, arthritis, and post-operative pain. Common analgesics include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen.
Analgesics are available in a variety of forms, including tablets, capsules, liquids, and topical creams. Many analgesics are available over-the-counter, while others require a prescription.
The analgesics market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the analgesics market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Merck. Show Less Read more